Dr. Sanda at BIDMC and researchers at the University of Michigan and Cornell are investigating whether a test to detect prostate cancer genes in urine (that could be used in conjunction with the PSA blood test) would help identify men who are at risk for more aggressive forms of prostate cancer, for whom biopsy and treatment would be appropriate.